The global bioreactors market is expected to reach US$ 4,811.5 Mn in
2027 from US$ 2,850.2 Mn in 2018. The market is estimated to grow with a
CAGR of 6.3% from 2019-2027.

The growth of the bioreactors market is primarily attributed to the
increasing investments in R&D and other activities. Moreover, the rapid
growth of pharmaceutical and biotechnology industry is also expected to
drive the growth of bioreactors market. However, availability of
alternative techniques for bioreactors and stringent regulatory
framework is expected to obstruct the growth of bioreactors market.

On the other hand, rapid use of single use bioreactors are expected to
be trending in the manufacturing companies and research institutes in
the market. The single-use bioreactors are helpful in providing
next-generation cell- and gene-therapies and continuous bioprocessing.
The betterments and improvements in cell-culture processes have
developed higher titers and cell densities, which have facilitated the
adoption of single-use bioreactors through reductions in needed reactor
volumes.

Single-use bioreactors reduce the risks of contamination from the other
products and decrease production turnaround times. Moreover, reduction
in validation time shortens time which is a tremendous value for the
advanced development of the bio products. The S.U.B. combines elements
of stirred-tank systems with the efficiencies in cleanup and validation
found in single-use processing, and supports scale-up needs and optimal
cell growth, viability, and general metabolism.

In 2018, the industrial scale (>1000L) bioreactors segment held a
largest market share of 63.4% of the bioreactors market, by product
class. This segment is also expected to dominate the market in 2027
owing to increasing demand for industrial scale (>1000L) bioreactors in
biotechnology and pharmaceutical companies. However, the pilot scale (15
– 1000L) bioreactors segment is anticipated to witness the fastest
growth rate of 6.8% during the forecast period, 2019 to 2027 owing to
the increased use of pilot scale bioreactors for research purposes.

Global bioreactors market, based on application was segmented into
microbial application and cell culture. Microbial application segment is
anticipated to grow at a CAGR of 6.5% during the forecast period. The
production of microbiologic and increasing government funding as well as
promotional initiatives undertaken for usage of microbial products to
treat medical conditions. Increasing R&D innovation in various other
microbial applications has also been contributing significantly to the
growth of the bioreactors market.

Some of the major primary and secondary sources for bioreactors included
in the report are World Health Organization (WHO), International
Federation of Pharmaceutical Manufacturers & Associations (IFPMA),
National Research Foundation (NRF), Biotechnology Industry Research
Assistance Council (BIRAC), Canadian Institutes of Health Research
(CIHR) and others.